understanding context dependent relevance of potential cancer drug targ
Published 8 years ago • 244 plays • Length 28:52Download video MP4
Download video MP3
Similar videos
-
37:40
jeffrey settleman, ph.d., the many flavors of resistance to anti-cancer drugs
-
56:36
targeting cancer pathways: the epigenetics question
-
8:59
intro to cell signaling
-
1:10:49
targeting cancer pathways: tumor resistance
-
56:42
targeting cancer pathways: the tumor microenvironment
-
59:06
creating new neurons: the potential to reverse parkinson’s disease
-
58:31
stanford cancer institute breakthroughs in cancer: luis diaz, md
-
59:34
oxygen, stress, and antioxidants (ron mittler, phd)
-
40:53
spatial imaging as a tool for discovery of new candidates to predict response to immunotherapies
-
1:09:21
copper conducted kinase signaling in cancer; donita brady, ph.d.
-
6:20:41
precision medicine: how far are we?
-
1:26:44
cell signaling in cancer: new targets, new hope
-
38:16
max jan - dana-farber targeted degradation webinar series
-
1:18:29
focus on: cancer signaling
-
1:02:20
#kcrs20: new molecular targets for kidney cancer
-
22:33
epigenetic therapy for lymphoma: from the laboratory to the clinic
-
53:45
intra-tumor heterogeneity and drug response
-
59:26
targeting cancer pathways: tumor metabolism and proliferation
-
38:01
menna clatworthy: novel functions for igg in modulating immune highways and dc traffickingficking
-
37:37
signaling pathways in cancer symposium: jeff settleman
-
1:31:21
lung cancer precision medicine summit
-
1:16:18
focus on: translational cancer and drug discovery